Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 5INDUSTRY 2INDIV 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 4Leiomyoma 3Lung Neoplasms 2Lipoma 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Barrett Esophagus 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Overweight 1Osteosarcoma 1Obesity 1Neutropenia 1Neoplasms, Squamous Cell 1Melanoma 1Lymphoma, Follicular 1Lymphoma 1Liver Neoplasms 1Leiomyomatosis 1Inflammatory Bowel Diseases 1Hypotrichosis 1Fibrosis 1Craniopharyngioma 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma in Situ 1Cancer Cachexia 1

Interventions

Microbial Collagenase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × INDIV × Lipoma × Clear all
NCT02249052 2017-02-23

Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma

Gerut, Zachary, M.D.

Phase 2 Completed
19 enrolled 11 charts

Lipoma

NCT01613313 2016-10-06

A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma

Gerut, Zachary, M.D.

Phase 2 Completed
14 enrolled 8 charts

Lipoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡